Certified by Founder
Lodge
Asimov
start up
United States
- Boston, Massachusetts
- 09/01/2023
- Series B
- $200,000,000
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
- Industry Biotechnology Research
- Website https://www.asimov.com/
- LinkedIn https://www.linkedin.com/company/asimov/